GlaxoSmithKline (GSK) Q3 EPS Falls to 22.6p; Revs Lower Y/Y

GlaxoSmithKline (NYSE: GSK) reported Q3 EPS of 22.6 pence, versus 27.2 pence reported last year. Revenue for the quarter came in at GBP6.53 billion, versus GBP7.1 billion reported last year.

For earnings history and earnings-related data on GlaxoSmithKline (GSK) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Wells Fargo cuts Netflix rating on engagement risk, weak slate
• Can global equities keep rising? UBS sees these factors driving upside
• Lucid Capital Markets Starts Bain Capital Specialty Finance (BCSF) at Neutral